Revolution Medicines, Inc. (RVMD)
NASDAQ·Healthcare·Biotechnology
$193.10
+5.84%
Mkt Cap $39.87B
Analyst Ratings
Buy
32
Hold
0
Sell
0
Price Target (46 analysts)
$176.08
Range $73.00 – $235.00
Implied Upside
-8.8%
Consensus $176.08 vs current $193.10
NASDAQ·Healthcare·Biotechnology
$193.10
+5.84%
Mkt Cap $39.87B
Buy
32
Hold
0
Sell
0
Price Target (46 analysts)
$176.08
Range $73.00 – $235.00
-8.8%
Consensus $176.08 vs current $193.10